Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
ALL, HSCs, Leukemia, Diseases, MDS, Biological Processes, DNA damage, Technology and Procedures, Cell Lineage, epigenetics, gene editing, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, hematopoiesis, inflammation, molecular testing, NGS, pathogenesis
Type: Oral
Hematology Disease Topics & Pathways:
ALL, HSCs, Leukemia, Diseases, MDS, Biological Processes, DNA damage, Technology and Procedures, Cell Lineage, epigenetics, gene editing, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, hematopoiesis, inflammation, molecular testing, NGS, pathogenesis
Sunday, December 6, 2020: 12:00 PM-1:30 PM
Moderators:
Lukasz P. Gondek, MD, PhD, Johns Hopkins
and
George S. Vassiliou, MD, PhD, FRCPath, MRCP, Wellcome - MRC Cambridge Stem Cell Institute, Wellcome Trust Sanger Institute
Disclosures:
Vassiliou: Kymab Ltd - Monoclonal antibody company. Currently not working in myeloid cancers or clonal haematopoiesis.: Consultancy.
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH